Association of <i>MTHFR</i> Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens-Reference-Cited by-同舟云学术

Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens

Published:2023-10-24 Issue:17 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Karschnia Philipp¹,Kurz Sylvia C.¹^ORCID,Brastianos Priscilla K.¹^ORCID,Winter Sebastian F.¹^ORCID,Gordon Amanda¹^ORCID,Jones SooAe¹^ORCID,Pisapia Michelle¹^ORCID,Nayyar Naema¹^ORCID,Tonn Joerg-Christian¹,Batchelor Tracy T.¹^ORCID,Plotkin Scott R.¹^ORCID,Dietrich Jorg¹^ORCID

Affiliation:

1. From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207670

Reference14 articles.

1. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

2. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

3. MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population

4. Leukoencephalopathy due to Oral Methotrexate

5. Influence ofADORA2Agene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Mental Status in Cancer;Seminars in Neurology;2024-08-05

2. GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS;Experimental Oncology;2024-02-03